Cargando…

Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment

BACKGROUND: Cardiotoxicity from anticancer therapy affects heart function and structure. Cardiotoxicity can also lead to accelerated development of chronic diseases, especially in the presence of risk factors. METHODS: This study aimed to develop and pilot a combined cardiovascular disease and cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Robyn A., Marin, Tania S., Berry, Narelle M., Atherton, John J., Foote, Jonathon W., Koczwara, Bogda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048103/ https://www.ncbi.nlm.nih.gov/pubmed/32154001 http://dx.doi.org/10.1186/s40959-017-0025-7

Ejemplares similares

Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
por: Clark, Robyn A., et al.
Publicado: (2019)

Characteristics of patients with haematological and breast cancer (1996–2009) who died of heart failure‐related causes after cancer therapy
por: Versace, Vincent L., et al.
Publicado: (2016)

Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance
por: Grover, Suchi, et al.
Publicado: (2014)

Bilateral intermediate uveitis following treatment with paclitaxel in a patient with invasive ductal carcinoma of the breast
por: Kvopka, Michael, et al.
Publicado: (2022)

Comorbidities and their management in women with breast cancer—an Australian survey of breast cancer survivors
por: Koczwara, Bogda, et al.
Publicado: (2023)

Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework
por: Dunn, Jeff, et al.
Publicado: (2021)

Finding My Way from clinical trial to open access dissemination: comparison of uptake, adherence, and psychosocial outcomes of an online program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2022)

Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
por: Ng, Huah Shin, et al.
Publicado: (2018)

Modality preferences for health behaviour interventions for post-treatment cancer survivors: a theoretical investigation
por: Leske, Morgan, et al.
Publicado: (2023)

Shared care involving cancer specialists and primary care providers – What do cancer survivors want?
por: Lawn, Sharon, et al.
Publicado: (2017)

Health status and mental distress in people with cancer and comorbid conditions: The Australian National Health Survey analysis
por: Ng, Huah Shin, et al.
Publicado: (2023)

Finding My Way: protocol of a randomised controlled trial evaluating an internet self-help program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2015)

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
por: Jiang, Jin, et al.
Publicado: (2022)

Cardiotoxicity assessment in breast cancer patients: is it straining?( )
por: Villarraga, Hector, et al.
Publicado: (2022)

Mapping Systematic Reviews of Breast Cancer Survivorship Interventions: A Network Analysis
por: Kemp, Emma B., et al.
Publicado: (2022)

Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy
por: Fradley, Michael G., et al.
Publicado: (2021)

The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab
por: Huszno, Joanna, et al.
Publicado: (2015)

Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin
por: Hallman, Briana E., et al.
Publicado: (2019)

Financial toxicity and employment status in cancer survivors. A systematic literature review
por: Mols, Floortje, et al.
Publicado: (2020)

Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services
por: Edge, Rhiannon, et al.
Publicado: (2021)

Assessment of acute radiation therapy-related cardiotoxicity by cardiovascular magnetic resonance
por: Traber, Julius, et al.
Publicado: (2016)

The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review
por: Conway, Aaron, et al.
Publicado: (2015)

Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial
por: Rüger, Alexandra Maria, et al.
Publicado: (2020)

Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
por: Smith, Gillian, et al.
Publicado: (2009)

Cancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study group
por: Chan, Alexandre, et al.
Publicado: (2020)

New Cardiotoxicity Risk Assessment Guidelines: Searching for Validation
por: Rashed, Eman R., et al.
Publicado: (2023)

‘Food for Thought’—The Relationship between Diet and Cognition in Breast and Colorectal Cancer Survivors: A Feasibility Study
por: Coro, Daniel G., et al.
Publicado: (2021)

Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection
por: Averin, A. S., et al.
Publicado: (2021)

Longitudinal automated assessments of myocardial strain from cine MR in cancer patients receiving cardiotoxic chemotherapy
por: Jolly, Marie-Pierre, et al.
Publicado: (2016)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021)

Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
por: Lee, Myunhee, et al.
Publicado: (2021)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014)

Preventing Cardiotoxicity in Personalized Breast Irradiation
por: Ippolito, Edy, et al.
Publicado: (2023)

Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging
por: Podlesnikar, Tomaž, et al.
Publicado: (2022)

Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
por: Contaldi, Carla, et al.
Publicado: (2023)

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer
por: Abbas, M. Nazim, et al.
Publicado: (2021)

Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Serum Biomarkers for Chemotherapy Cardiotoxicity Risk Detection of Breast Cancer Patients
por: Hasan, Diya, et al.
Publicado: (2021)

Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
por: Li, Xinyi, et al.
Publicado: (2021)

Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis
por: Zhang, Meilin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u1tj031t2dsl0bf2a9ok74pg6u